Search
CP-122721
go.drugbank.com/drugs/DB05421ExperimentalCP-122721, neurokinin 1 (NK1) antagonist is developed by Pfizer to treat depression, emesis, and inflammatory diseases including asthma and irritable bowel syndrome.
Rusalatide acetate
go.drugbank.com/drugs/DB11668InvestigationalChrysalin has been used in trials studying the treatment of Radius Fracture.
Equol
go.drugbank.com/drugs/DB11674InvestigationalEquol has been used in trials studying the treatment of Breast Cancer.
UK-390957
go.drugbank.com/drugs/DB11719InvestigationalUK-390,957 has been used in trials studying the treatment of Ejaculation.
Talinolol
go.drugbank.com/drugs/DB11770InvestigationalTalinolol has been investigated for the basic science of Gastrointestinal Motility Disorder.
Allicin
go.drugbank.com/drugs/DB11780InvestigationalAllicin has been used in trials studying the treatment of Follicular Lymphoma.
Apimostinel
go.drugbank.com/drugs/DB11784InvestigationalNRX-1074 has been used in trials studying the treatment of Schizophrenia.
Ginsenosides
go.drugbank.com/drugs/DB14152InvestigationalDammarane type triterpene saponins based mainly on the aglycones, protopanaxadiol and protopanaxatriol.
Autologous pancreatic islets
go.drugbank.com/drugs/DB18521InvestigationalAutologous pancreatic islet therapy involves isolating the patient's own insulin-producing cells.
GSBR-1290
go.drugbank.com/drugs/DB18551InvestigationalGSBR-1290 is a small molecule agonist of the GLP-1 receptor.